Vapotherm Investor Relations Material
Latest events
Q3 2023
Vapotherm
Q2 2024
12 Aug, 2024
Q1 2024
9 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vapotherm Inc
Access all reports
Vapotherm Inc develops and manufactures respiratory care devices, specializing in high-velocity nasal insufflation therapy for patients with respiratory distress. The company markets its products to hospitals and other acute care settings. The company is headquartered in Exeter, New Hampshire, and its shares are listed on the NYSE.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
VAPO
Country
🇺🇸 United States